MariMed (OTCMKTS:MRMD) Issues Earnings Results

MariMed (OTCMKTS:MRMD) announced its quarterly earnings data on Wednesday. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01), Zacks reports. MariMed had a negative return on equity of 5.85% and a negative net margin of 8.94%.

MariMed Price Performance

MRMD stock traded up $0.00 during midday trading on Wednesday, reaching $0.08. The stock had a trading volume of 810,925 shares, compared to its average volume of 568,040. The company’s fifty day simple moving average is $0.08 and its 200 day simple moving average is $0.09. The company has a current ratio of 1.00, a quick ratio of 0.38 and a debt-to-equity ratio of 1.44. The company has a market cap of $33.51 million, a price-to-earnings ratio of -2.80 and a beta of 1.33. MariMed has a 52-week low of $0.06 and a 52-week high of $0.23.

About MariMed

MariMed Inc is a multi?state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult?use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre?rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.